Recombinant Human Fibrinogen gamma chain(FGG)

Code CSB-YP008651HU
Size Pls inquire
Source Yeast
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP008651HU-B
Size Pls inquire
Source E.coli
Conjugate Avi-tag Biotinylated
E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-BP008651HU
Size Pls inquire
Source Baculovirus
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-MP008651HU
Size Pls inquire
Source Mammalian cell
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Purity >85% (SDS-PAGE)
Target Names FGG
Uniprot No. P02679
Alternative Names FGG; FIBG_HUMAN; Fibrinogen gamma chain; Fibrinogen gamma polypeptide; fibrinogen gamma-b chain
Species Homo sapiens (Human)
Expression Region 27-453
Target Protein Sequence YVAT RDNCCILDER FGSYCPTTCG IADFLSTYQT KVDKDLQSLE DILHQVENKT SEVKQLIKAI QLTYNPDESS KPNMIDAATL KSRKMLEEIM KYEASILTHD SSIRYLQEIY NSNNQKIVNL KEKVAQLEAQ CQEPCKDTVQ IHDITGKDCQ DIANKGAKQS GLYFIKPLKA NQQFLVYCEI DGSGNGWTVF QKRLDGSVDF KKNWIQYKEG FGHLSPTGTT EFWLGNEKIH LISTQSAIPY ALRVELEDWN GRTSTADYAM FKVGPEADKY RLTYAYFAGG DAGDAFDGFD FGDDPSDKFF TSHNGMQFST WDNDNDKFEG NCAEQDGSGW WMNKCHAGHL NGVYYQGGTY SKASTPNGYD NGIIWATWKT RWYSMKKTTM KIIPFNRLTI GEGQQHHLGG AKQVRPEHPA ETEYDSLYPE DDL
Protein Length Full Length of Mature Protein
Tag Info The following tags are available.
N-terminal His-tagged
Tag-Free
The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
Form Lyophilized powder
Buffer before Lyophilization Tris/PBS-based buffer, 6% Trehalose, pH 8.0
Reconstitution We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Troubleshooting
and FAQs
Protein FAQs
Storage Condition Store at -20°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Shelf Life The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Lead Time Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
Notes Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet Please contact us to get it.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Earn $30 Amazon Card or 20μL/μg CUSABIO Trial Size Antibody. Details of rewards >>

Target Data

Function Together with fibrinogen alpha (FGA) and fibrinogen beta (FGB), polymerizes to form an insoluble fibrin matrix. Has a major function in hemostasis as one of the primary components of blood clots. In addition, functions during the early stages of wound repair to stabilize the lesion and guide cell migration during re-epithelialization. Was originally thought to be essential for platelet aggregation, based on in vitro studies using anticoagulated blood. However, subsequent studies have shown that it is not absolutely required for thrombus formation in vivo. Enhances expression of SELP in activated platelets via an ITGB3-dependent pathway. Maternal fibrinogen is essential for successful pregnancy. Fibrin deposition is also associated with infection, where it protects against IFNG-mediated hemorrhage. May also facilitate the antibacterial immune response via both innate and T-cell mediated pathways.
Gene References into Functions
  1. These data suggest that single nucleotide polymorphisms ABO rs8176719 and FGG rs2066865 may contribute individually to the venous thromboembolism susceptibility in the Portuguese population. PMID: 29995659
  2. DNA sequencing revealed a novel heterozygous CCTTTGATG deletion in the exon 8 of FGG, leading to the deletion of Ala289, Phe290, and Asp291 in fibrinogen gamma-chain PMID: 29748775
  3. The simultaneous retention of fibrinogen and APOB-lipoproteins in FSD can be detected in routinely stained histological sections. The analysis of protein structures unraveled the pathomorphogenesis of this unexpected phenomenon. Fibrinogen gamma chain mutations provoke conformational changes in the region of the globular domain involved in the "end-to-end" interaction, thus impairing the D-dimer formation PMID: 29244742
  4. The D356V (D330V) mutation located in the C-terminus was predicted to be highly deleterious and to affect the function of the protein. The obtained computational results suggest that the substitution of the neutral amino acid valine for the acidic amino acid aspartic acid at position 356 results in an unwound conformation within 50 ns, which might contribute to defective polymerization. PMID: 27677677
  5. Fibrinogen gamma acts as thrombomodulin II. (Review) PMID: 27784620
  6. Gene analysis of the fibrinogen phenotype reveals the importance of polygenic co-regulation. PMID: 27771416
  7. Fibrinogen gamma chain and complement factor H were found to be bound as a protein complex in the plasma of a patient with advanced ovarian cancer PMID: 28551622
  8. Our data indicate that the amplitude and maximal velocity of coagulation curves from plasma samples from FGG p.Arg301(275)Cys dysfibrinogenemic patients were comparable to those from plasma samples with fibrinogen in the normal range, whereas the amplitude of coagulation curves from patients with acquired low fibrinogen levels was lower PMID: 28318107
  9. These results suggest that among the elderly, gamma ' fibrinogen does not add much to cardiovascular disease prediction beyond traditional risk factors and total fibrinogen level. PMID: 27180117
  10. rs2066865 polymorphism has an important role in the development of venous thromboembolism in the white race PMID: 28353616
  11. Gene polymorphisms FGG C>T (rs6536024) were not associated with height, weight, or morbid obesity among European subjects. PMID: 27999448
  12. A lower plasma concentration of gamma' gamma fibrinogen in healthy adults does not appear to increase venous thromboembolism risk. PMID: 26916295
  13. In addition to the reduction of FG concentration expected by the nature of the mutation also a functional defect (hypodysfibrinogenemia) was found. Moreover this mutation seems to increase the risk of thrombosis warranting long term anticoagulation possibly in a combination with antiplatelet drugs. PMID: 26540127
  14. congenital dysfibrinogenemia with a novel mutation in fibrinogen gamma chain (gamma322 Phe-->Ile, Fibrinogen Beijing) and haemophilia B in a family PMID: 25982359
  15. 5877G>A mutation in the exon 8 of the FGG gene is underlies the pathogenesis of congenital dysfibrinogenemia in a Chinese family. PMID: 27060305
  16. Case Reports: clustering of mutations causing fibrinogen storage disease in the fibrinogen gamma chain between residues 284 and 375. PMID: 26039544
  17. Data indicate that mutations of the fibrinogen (Fg) gene seem to aggregate to the D region of fibrinogen gamma chain (FGG) PMID: 26663050
  18. Letter/Case Report: FGG 320Asp-Glu substitution that displayed both a quantitative and functional defect and presented as hypodysfibrinogenaemia. PMID: 25042726
  19. Low FI levels are strongly associated with rare CFI variants and age-related macular degeneration. PMID: 25788521
  20. Report role of gamma'-fibrinogen in control of hemostatic clot growth in the venous circulation. PMID: 25614284
  21. Letter/Case Report: FGG 339CysSer mutation causes only hypofibrinogenaemia. Accompanying functionality change is due to increased sialylation and inheritance of the B448Lys allele. PMID: 25588350
  22. Suggest gamma' fibrinogen concentrations reflect general inflammation that accompanies and may contribute to atherosclerotic CVD, instead of gamma' fibrinogen being a causal risk factor. PMID: 26494231
  23. This study shows that homocysteine influences blood clot properties alone and in combination with total fibrinogen but not with fibrinogen gamma' isoform in Africans. PMID: 25688462
  24. investigated molecular basis of dysfibrinogenaemia in a Chinese pedigree; sequencing results of proband revealed a novel heterozygous IVS9+1delG mutation of FGG gene; same results were found in her mother sister and daughter; concluded the mutation is responsible for the proband's dysfibrinogenaemia PMID: 25551304
  25. Data indicate that leptin receptor gene (LEPR) single-nucleotide polymorphisms (SNPs) rs4291477 significantly associated with serum fibrinogen. PMID: 25296580
  26. A novel mutation in FGG gene is associated with congenital hypofibrinogenemia. PMID: 26037343
  27. Final clot structure may contribute to increased cardiovascular disease (CVD) risk in vivo through associations with other CVD risk factors independent from total or gamma' fibrinogen concentration. PMID: 25213709
  28. Novel fibrinogen mutations (gammaTrp208Leu and gammaLys232Thr) leading to congenital hypofibrinogenemia in two unrelated Chinese families have been described. PMID: 24914742
  29. Exploratory multilocus polygenic analyses with p <0.05 showed an association of optimism with SNPs in MAOA, IL10, and FGG genes, and an association of resilience with a SNP in MAOA. PMID: 24791650
  30. While the gamma Ser313Gly mutation manifested as dysfibrinogenemia with a thrombotic background, the gamma Phe204Val mutation manifested as hypofibrinogenemia without clinical symptoms. PMID: 25074738
  31. observed increased APC resistance in carriers of fibrinogen gamma gene (FGG) haplotype 2, which is associated with reduced levels of the alternatively spliced fibrinogen gamma' chain. We then studied the effects of fibrinogen and its gamma' chain on APC resistance. PMID: 24951429
  32. novel causitive mutation is identified in a New Zealand family with hypofibrinogenaemia PMID: 24352576
  33. elevated levels of gammaA/gammaA fibrinogen promote arterial thrombosis in vivo, whereas gammaA/gamma' does not PMID: 24916154
  34. Reduced plasminogen binding and delayed activation render gamma'-fibrin more resistant to lysis than gammaA-fibrin. PMID: 25128532
  35. report of 2 hypofibrinogenemias, Shizuoka III and Kanazawa II, caused by heterozygous nonsense mutation at the fibrinogen gamma-chain, gamma23X and gamma376X, respectively; analysis demonstrated the transcribed aberrant mRNAs from both gamma23X and gamma376X genes are degraded by nonsense-mediated mRNA decay and not translated to the truncated polypeptide PMID: 24011387
  36. A heterozygous point mutation located in exon 3 of the FGG gene c.140C>T (p.Thr21Ile)was found in a patient and her mother, both of whom had hypofibrinogenemia. PMID: 24556703
  37. A novel FGG mutation is associated with hypofibrinogenemia. PMID: 23492915
  38. A decreased number of factor XIIIa+ cells is found in the lower dermis following pulsed dye laser treatment. PMID: 23645504
  39. Results indicate that the alphaC domain of fibrinogen harbors a Zn(2+)-dependent heparin binding site. PMID: 23990470
  40. Data indicate that the adhesive alpha-granule proteins fibrinogen and thrombospondin are concentrated in a fibrin polymerization-dependent "cap" on phosphatidylserine-expressing platelets that promotes their incorporation into thrombi. PMID: 23995838
  41. Letter/Case Report: deep vein thrombosis associated with novel substitution (gamma346Gly-->Val) at an absolutely conserved site in the fibrinogen gamma chain. PMID: 23348147
  42. fibrinogen gamma' may contribute to the development of portal vein thrombosis PMID: 23306717
  43. Clot lysis time showed a stronger relationship with fibrinogen gamma' than with total fibrinogen, whereby increased fibrinogen gamma' delayed clot lysis. PMID: 23422752
  44. HepG2 cell gamma' fibrinogen is disproportionately up-regulated by inflammatory responses induced by interleukin-6. PMID: 23036532
  45. A novel congenital Fibrinogen Melbourne hypodysfibrinogenemia caused by g326Cys-Phe in the fibrinogen gamma chain, presenting as massive splanchnic venous thrombosis, has been described in one patient and his asymptomatic father. PMID: 22760446
  46. Fibrinogen gamma' is associated with the formation of mechanically weaker, non-uniform clots composed of thin fibers. This is caused by direct disruption of protofibril formation by gamma'. PMID: 22463367
  47. Fibrinogen residue gammaAla341 is important for the proper conformation of the gamma-module, maintaining calcium-binding site and 'A-a' interactions. PMID: 22437918
  48. mechanical unraveling of fibrin(ogen) is determined by the combined molecular transitions that couple stepwise unfolding of the gamma chain nodules and reversible extension-contraction of the alpha-helical coiled-coil connectors PMID: 22078561
  49. gamma' fibrinogen is associated with prevalent cardiovascular disease and with SNPs exclusively in and near the fibrinogen gene locus. PMID: 21757653
  50. potential biomarker for assessing a patient's inflammatory state and associated cardiovascular disease risk PMID: 21174007

Show More

Hide All

Involvement in disease Congenital afibrinogenemia (CAFBN); Dysfibrinogenemia, congenital (DYSFIBRIN)
Subcellular Location Secreted
Tissue Specificity Detected in blood plasma (at protein level).
Database Links

HGNC: 3694

OMIM: 134850

KEGG: hsa:2266

STRING: 9606.ENSP00000336829

UniGene: Hs.727584

Newsletters

Get all the latest information on Events, Sales and Offers. Sign up for newsletter today.

© 2007-2021 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1